Down-regulation of the protein kinase A pathway by activators of protein kinase C and intracellular Ca2+ in fibroblast cells  by Döbbeling, Udo & Berchtold, Martin W.
FEBS 17355 FEBS Letters 391 (1996) 131-133 
Down-regulation of the protein kinase A pathway by activators of 
protein kinase C and intracellular Ca 2+ in fibroblast cells 
Udo D6bbeling*, Martin W. Berchtold 
Institut fiir Veteringirbiochemie der Universitiit Ziirich, Winterthurerstrasse 190, CH-8057 Zfirich, Switzerland 
Received 22 May 1996; revised version received 17 June 1996 
Abstract Many genes are regulated by the intracellular 
calcium, protein kinase C (PKC) and protein kinase A (PKA) 
pathways and it has been shown that these pathways ynergize in 
some cell types, whereas they antagonize in others. Here we show 
that the calcium and PKC pathways suppress the effects 
mediated by the PKA pathway in a fibroblast cell line. The 
suppressing effect of elevated intracellular Ca 2+ levels, but not of 
the PKC pathway, can be abrogated by the addition of 
cyclosporin A (CsA), indicating that the effect of Ca 2÷ is 
mediated by phosphatase-2B (PP-2Blcalcineurin). Suppression 
by the PKC pathway is not mediated by the proto-oncogenes c-
fos, c-jun andjunB, as the co-transfection of these genes does not 
block the effects of the PKA stimulator 8-Br-cAMP. In addition, 
cotransfection with the catalytic subunit of PKA shows that the 
inhibitory effect of PKC occurs upstream of PKA activation. 
Key words: Signal transduction; Gene regulation; 
Transcription factor; Cross-talk of signalling pathways 
I. Introduction 
The cell receives many signals from outside through differ- 
ent signalling pathways. Among the most studied pathways 
are the protein kinase A (PKA), protein kinase C (PKC) and 
Ca 2+ pathways. The PKC and Ca z+ pathways nearly always 
synergize, as they are often triggered simultaneously by a 
membrane-bound receptor, whereas depending on the cell 
type, they sometimes antagonize or synergize with the PKA 
pathway [1]. 
The individual signalling pathways have been studied inten- 
sively; however, less work has been devoted to elucidate the 
mechanisms of the interactions among the different signalling 
pathways. To study the antagonism of the PKA, PKC and 
Ca 2+ pathways in mouse fibroblasts we used defined reporter 
plasmids containing cAMP responsive lements (CRE) or 
TPA responsive lements (TRE) in front of the chloramphe- 
nicol acetyl transferase (CAT) reporter gene. The CREs are 
targets of the transcription factor CREB [2] which is activated 
through the PKA and Ca2+/calmodulin pathways, whereas 
the TREs are targets of the products of the fos and jun gene 
families which are activated by the PKC pathway [3] and 
elevated levels of intracellular Ca 2+ [4]. The results we ob- 
tained with this system show that the PKC and Ca 2+ path- 
ways dominate over the PKA pathway in mouse fibroblasts 
when they are stimulated at the same time. 
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2. Material and methods 
2.1. Cell culture and transient DNA transfection 
L4 cells [5] which are derivatives of the mouse fibroblast cell line 
NIH 3T3 were grown in Dulbecco's modified Eagle medium 
(DMEM), supplemented with 10% new-born calf serum (NBCS), 
2.5 ~tg/ml amphotericin B, 5 mg/ml gentamicin, and 2 mM glutamine 
and were transfected by calcium phosphate co-precipitation asde- 
scribed in [6] 
2.2. Expression vectors 
The expression vector pCEV contains the catalytic subunit (c alpha) 
of the mouse PKA [7], whose expression is driven by the metal ion- 
inducible mouse metallothionein promoter. The expression ofc-fos, c- 
jun, andjunB was driven from the RSV (Rous sarcoma virus) enhanc- 
er of their vectors RSV-c-fos [8], RSV-c-jun [9], and RSV-junB [10]. 
Expression of the beta-galactosidase ref rence gene was driven from 
the CMV (cytomegalovirus) enhancer of the expression vector pCMV- 
beta-gal. 
2.3. CAT assay 
Chloramphenicol acetyl transferase (CAT) assays were performed 
mainly following the protocol of Gorman et al. [11] with the exception 
that the whole-cell extracts were heated to 65°C for 10 rain to destroy 
deacylases and that the incubation time was extended to 16 h. As 
reporter genes we used 2×SOM-CRE-CAT [12] containing two 
CREs of the somatostatin gene [2] in front of a TATA-box and the 
CAT gene; and 5× TRE-CAT [13] in which five TPEs [3] have been 
inserted in front of a TATA-box and the CAT gene. For each experi- 
ment three independent transfections were carried out and each 
whole-cell extract obtained was tested twice for CAT activity. From 
the resulting six measurements theaverage value and standard evia- 
tion were obtained. The CAT assays were standardized by cotrans- 
fecting 0.1 ~tg of the expression vector pCMV-beta-gal by and meas- 
uring the beta-galactosidase ctivity of whole-cell extracts prepared 
from one-quarter of the transfected cells. 
3. Results 
3.1. Stimulation of  gene transcription by the PKA, PKC and 
Ca 2+ signalling pathways in L4 cells 
We first studied the effect of 8-Br-cAMP (1 mM) on the 
reporter plasmid 2×SOM-CRE-CAT [12] in the absence and 
presence of thapsigargin (10 nM) a mobilizer of intracellular 
calcium. Fig. 1 shows that 8-Br-cAMP stimulates CAT from 
the 2 × SOM-CRE-CAT plasmid approximately 5-fold. This 
stimulation is totally reversed when 8-Br-cAMP and thapsi- 
gargin are given simultaneously. The same effects are observed 
when instead of the 8-Br-cAMP treatment the catalytic sub- 
unit of PKA was co-transfected. The addition of cyclosporin 
A (CsA, 10 ng/ml), an inhibitor of the calcium-dependent 
phosphatase PP-2B (calcineurin) [14] totally relieved the sup- 
pressing effect of thapsigargin, indicating that the effect of 
thapsigargin is mediated by this phosphatase. The same effects 
are observed when instead of 8-Br-cAMP treatment the cata- 
lytic subunit of PKA is transfected into L4 fibroblasts, i.e., the 
approximate 6-fold stimulation by the PKA catalytic subunit 
is suppressed by thapsigargin and this suppression is relieved 
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by CsA. These experiments indicate that the dominance of the 
Ca 2+ pathway over the PKA pathway is mediated by PP-2B. 
We next tested whether the PKC activator TPA had an 
effect on 8-Br-cAMP and PKA catalytic subunit-stimulated 
CAT expression from the 2x  SOM-CRE-CAT reporter plas- 
mid. Fig. 2 shows that the 8-Br-cAMP-stimulated CAT gene 
expression from this plasmid is totally blocked by TPA. In 
contrast o thapsigargin this suppression is not relieved by 
CsA. This result indicates that suppression of the PKA path- 
way by TPA is not mediated by PP-2B. 
To see whether the effect of TPA is mediated by the tran- 
scription factor AP-1, we transfected expression vectors for 
the c-fos and c-jun gene together with the 2×SOM-CRE- 
CAT reporter plasmid into IA fibroblast cells and treated 
them with mM 8-Br-cAMP. The AP-1 transcription factor is 
a heterodimer of the gene products of members of the jun and 
fos gene families and is activated by TPA. AP-1 binds to a 
DNA sequence which is very similar to that of CREB and it 
may be possible that the competition for the CREB binding 
sites on 2 x SOM-CRE-CAT may lead to the reduction of the 
CAT gene expression we observed with TPA. 
Fig. 2 shows that the co-transfection of expression vectors 
of c-fos and c-jun which form the most potent AP-1 complex 
has no effect on 8-Br-cAMP-stimulated gene expression. As 
gene expression mediated by AP-1 molecules from the CREs 
of 2XSOM-CRE-CAT may be responsible for the increased 
CAT expression we also transfected thejunB gene. The JUNB 
protein is a quite poor transactivator [15] and often even 
blocks AP-l-mediated transcription [9]. Also this molecule 
did not block 8-Br-cAMP-mediated stimulation of gene tran- 
scription (Fig. 2), indicating that competition for DNA bind- 
ing sites is not the mechanism that mediates the suppression 
of the PKA pathway by TPA. Control experiments with 
2XSOM-CRE-CAT and AP-1 in the absence of 8-Br-cAMP 
showed that AP-1 alone could not activate CA T transcription 
from this reporter plasmid (data not shown). 
We also tested the effect of TPA on the PKA catalytic 
subunit. Fig. 2 (lower panels) shows that in contrast o thap- 
sigargin TPA cannot block the activity of the PKA catalytic 
subunit and that this molecule is not the target of TPA-in- 
duced suppression of the PKA pathway. TPA therefore must 
act upstream of PKA activation. 
We further tested the influence of 8-Br-cAMP on TPA and 
thapsigargin-stimulated transcription using the plasmid 
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Fig. 1. Suppression of the activation (S) of gene expression by 8-Br- 
cAMP and the PKA catalytic subunit by the intracellular Ca 2+ mo- 
bilizer thapsigargin i  LA fibroblast cells, using the reporter plasmid 
2XSOM-CRE-CAT. The inducing and repressing agents are given 
on the left. CAT activity obtained from untreated cells (no) is set as 
1.0. Standard eviation is indicated by error bars. 
no- 
Br-cAMP 
Br-eAMP+TPA -
Br-eAMP+TPA+CsA - 
Br-cAMP+AP- 1 
Br-cAMP+junB 
PKA cat. s. 
pKA eat. s. +TPA- 
PKA eat. s.+Thaps. - 
---4 
i i i i S 
2 4 6 8 
Fig. 2. The effect of TPA, AP-I, junB and CsA on 8-Br-cAMP and 
PKA catalytic subunit-stimulated gene transcription from the 
2XSOM-CRE-CAT reporter plasmid. The stimulation factors (S) 
have been obtained as described in Fig. 1. 
5X TRE-CAT which contains five AP-1 binding sites (TRE) 
in front of the CA T reporter gene. We found that 8-Br-cAMP 
cannot suppress the PKC- and Ca2+-dependent signalling 
pathways (Fig. 3). This result implies that there is no PKA- 
regulated pathway which is able to block the action of the 
PKC and Ca ~+ pathways in IA cells. 
4. Discussion 
Our results show that there is in 1A fibroblasts an antago- 
nism between the PKA signalling pathway on the one side and 
the PKC and Ca 2+ signalling pathways on the other side. This 
antagonism is not reciprocal, as the latter two pathways dom- 
inate over the PKA pathway. The bias between these path- 
ways is not due to the concentrations of the agents we used, as 
1 mM 8-Br-cAMP turned out to be the optimal concentration, 
and concentrations higher than 1 mM 8-Br-cAMP reduced the 
cell growth and had a lower stimulating effect on gene tran- 
scription. 
The dominance of the Ca ~+ pathway over the PKA path- 
way is mediated by PP-2B as the PP-2B inhibitor CsA totally 
blocked the effect of the Ca 2+ mobilizer thapsigargin. Our 
experiments also show that the stimulating effect of the 
PKA catalytic subunit can be blocked by intracellular Ca 2+, 
indicating that the catalytic subunit is one of the targets of the 
repression of the PKA pathway by high intracellular Ca 2+ 
levels. PP-2B itself can dephosphorylate the regulatory sub- 
unit of PKA and thus favours the formation of the inactive 
PKA holoenzyme [16]. Eventually PP-2B does not only exert 
its effect by dephosphorylation f the catalytic subunit of 
PKA, but may also act in the same way that has been estab- 
lished for the glycogen metabolism [16,17] where PP-2B also 
de-represses the activity of the phosphatase PP-1 by inactiva- 
tion of the PP-1 inhibitor 1 (I-1). PP-1 in turn dephosphoryl- 
ates and inactivates substrates of PKA such as the transcrip- 
tion factor CREB [18]. A similar mechanism has also been 
found in dopaminoceptive n urons where the firing rate of the 
neurons is decreased by dopamine acting through cyclic AMP. 
This effect is overcome by glutamate acting via Ca z+ and this 
mechanism also involves derepression of PP-1. In this system 
DARPP 32, a homologue of I-1, is inactivated by PP2B 
[19,20] leading to de-repression of PP-1 which in turn inacti- 
vates substrates of PKA. 
In their ability to repress PKA-dependent gene expression 
by Ca 2+, L4 fibroblast cells differ markedly from other cell 
types [21-23] which activate the PKA pathway by Ca 2+ 
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Fig. 3. The influence of 8-Br-cAMP on the TPA- and thapsigargin- 
induced gene transcription from the reporter plasmid 5x TRE-CAT. 
The stimulation factors (S) have been obtained as described in 
Fig. 1. 
through the Ca2+/calmodulin-dependent protein kinase II 
(CaM kinase II). We suppose that the PP-2B activity in L4 
cells is much higher than the one of CaM kinase II. The 
different activity of certain protein kinases or phosphatases 
may explain the phenomenon that different signalling path- 
ways synergize in some cell types, whereas they antagonize in
others [1]. 
PKC activation suppresses the stimulating PKA effect in 
another way than Ca 2+. The fact that CsA does not relieve 
the suppressing effect of the PKC pathway on the PKA acti- 
vation by 8-Br-cAMP excludes that PP-2B is involved in sup- 
pression of the PKA pathway by TPA. This conclusion is 
corroborated by the finding that the effect of the PKA cata- 
lytic subunit is not suppressed by the PKC pathway. 
The suppression of the PKA pathway by PKC activators i
also not effected on the level of transcription factors, as 
neither AP-1 (cJUN/cFOS heterodimer) nor JUNB can sup- 
press the stimulation of gene transcription by the PKA acti- 
vator 8-Br-cAMP. Therefore it seems that these and PKA- 
activated transcription factors do not compete for DNA bind- 
ing sites or co-factors, as it has been shown in other systems 
[13,24]. This result also shows that AP-1 and JUNB do not 
activate another activity which blocks the PKA pathway. 
In summary our results show that inhibition of the PKA 
pathway occurs upstream of the PKA catalytic subunit and 
downstream of adenylate cyclase. Our findings leave only the 
PKA holoenzyme as a target for the PKC-mediated repres- 
sion. This assumption is corroborated by the results of Gallo 
et al. [25] who have shown that TPA blocks the dissociation 
of the PKA holoenzyme and the translocation of the catalytic 
subunit into the nucleus. 
Acknowledgements." Wewould like to thank professor Clive C. Kuen- 
zle for his encouragement a d helpful discussion. We want also to 
express our thanks to Professors Gfinter Schiitz and G. Stanley 
McKnight for making the expression vector for the PKA catalytic 
subunit and the reporter gene 2 x SOM-CRE-CA T available and Dr. 
Peter Angel, for the expression plasmids of the jun and fos family 
genes and the reporter gene 5xTRE-CAT. This work and U.D. 
were financially supported by the Kanton of Zurich. 
References 
[1] Nishizuka, Y. (1986) Science 233, 305-312. 
[2] Montminy, M.R. Sevarino, K.A., Wagner, J.A., Mandel, G. and 
Goodman, R.H. (1986) Proc. Natl. Acad. Sci. USA 83, 668~ 
6686. 
[3] Angel, P., Imagawa, M., Chiu, R., Stein, B., Imbra, R.J., Rahms- 
doff, H.J., Jonat, Herrlich, P. and Karin, M. (1987) Cell 49, 729- 
739. 
[4] Schrnthal, A., Sugarman, J., Brown, J.H., Hanley, M.R. and 
Feramisco, J.R. (1991) Proc. Natl. Acad. Sci. USA 88, 7096 
7100. 
[5] Schatz, D.G., Oettinger, M.A. and Baltimore, D. (1989) Cell 59, 
1035-1048. 
[6] Westin, G., Gerster, T., Miiller, M.M., Schaffner, G. and Schaff- 
ner, W. (1987) Nucl. Acids Res. 15, 6787~798. 
[7] Uhler, M.D. and McKnight, G.S. (1987) J. Biol. Chem. 262, 
15202-15207. 
[8] Chiu, R., Boyle, W.J., Meek, J., Smeal, T., Hunter, T. and Karin, 
M. (1988) Cell 54, 541-552. 
[9] Angel, P., Hattori, K., Smeal, T. and Karin, M. (1988) Cell 55, 
875-885. 
[10] Chiu, R. Angel, P. and Karin, M. (1989) Cell 59, 979-986. 
[11] Gorman, C.M., Moffat, L.M. and Howard, B.H. (1982) Mol. 
Cell. Biol. 2, 1044-1051. 
[12] Boshart, M., Weih, F., Schmidt, A., Fournier, K.R.E. and 
Schiitz, G. (1990) Cell 61, 905-916. 
[13] Jonat, C., Rahmsdorf, H.J., Park, K.-K., Cato, A.C.B., Gebel, 
S., Ponta, H. and Herrlich, P. (1990) Cell 62, 1189-1204. 
[14] Schreiber, S.L. and Crabtree, G.R. (1992) Immunol. Today 13, 
136142. 
[15] Deng, T. and Karin, M. (1993) Genes Dev. 7, 479490. 
[16] Blumenthal, D.K., Takio, K., Hansen, R.S. and Krebs, E.G. 
(1986) J. Biol. Chem. 261, 8140-8145. 
[17] Cohen, P. (1989) Annu. Rev. Biochem. 58, 453-508. 
[18] Hagiwara, M., Alberts, A., Brindle, P., Meinkoth, J., Feramisco, 
J.R., Deng, T., Karin, M., Shenolikar, S. and Montminy, M. 
(1992) Cell 70, 105-113. 
[19] Hemmings, H.C., Greengard, P., Lim Tung, H.Y. and Cohen, P. 
(1984) Nature 310, 503-505. 
[20] Halpain, S., Girault, J.-A. and Greengard, P. (1990) Nature 343, 
369-372. 
[21] Dash, P.K., Karl, K.A., Colicos, M.A. Prywes, R. and Kandel, 
E.R. (1991) Proc. Natl. Acad. Sci. USA 88, 5061-5065. 
[22] Sheng, M., Thompson, M.A. and Greenberg, M.E. (1991) 
Science 252, 1427-1430. 
[23] Schwaninger, M., Lux, G., Blume, R., Oetjen, E., Hidaka, H. 
and Knepel, W. (1993) Biol. Chem. 268, 5168-5177. 
[24] Wieland, S., Drbbeling, U. and Rusconi, S. (1991) EMBO J. 10, 
2513-2521. 
[25] Gallo, A., Benusiglio, E., Bonapace, I.M., Feliciello, A., Cassa- 
no, S., Garbi, C., Musti, A.M., Gottesman, M.E. and Avvedi- 
mento, E.V. (1992) Genes Dev. 6, 1621-1630. 
